Corcept Therapeutics
CORT
#2097
Rank
NZ$15.47 B
Marketcap
NZ$146.84
Share price
2.60%
Change (1 day)
44.87%
Change (1 year)

Earnings for Corcept Therapeutics (CORT)

Earnings in 2025 (TTM): NZ$0.11 Billion

According to Corcept Therapeutics 's latest financial reports the company's current earnings are NZ$0.74 Billion. In 2024 the company made an earning of NZ$0.23 Billion, an increase over its 2023 earnings that were of NZ$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corcept Therapeutics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$0.11 B-52.39%
2024 NZ$0.23 B27.66%
2023 NZ$0.18 B-4.75%
2022 NZ$0.19 B-9.51%
2021 NZ$0.21 B-2.91%
2020 NZ$0.22 B14.87%
2019 NZ$0.19 B24.71%
2018 NZ$0.15 B69.32%
2017 NZ$90.97 M419.26%
2016 NZ$17.52 M-395.64%
2015 -NZ$5.93 Million-87.53%
2014 -NZ$47.54 Million-33.44%
2013 -NZ$71.43 Million
2011 -NZ$55.65 Million17.84%
2010 -NZ$47.23 Million35.5%
2009 -NZ$34.86 Million2.84%
2008 -NZ$33.89 Million60.81%
2007 -NZ$21.08 Million-52.14%
2006 -NZ$44.04 Million20.91%
2005 -NZ$36.42 Million31.87%
2004 -NZ$27.62 Million60.54%
2003 -NZ$17.21 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$55.75 B 49,305.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$13.82 B 12,150.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$28.26 B 24,939.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
NZ$38.73 B 34,218.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$20.39 B 17,974.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$39.74 B 35,113.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-NZ$47.24 Million-141.85%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
NZ$52.98 M-53.05%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$1.16 B 935.92%๐Ÿ‡บ๐Ÿ‡ธ USA